Professor of biotechnology appointed as new executive editor of prestigious journalAugust 4, 20222 min read
A biotechnology professor in the College of Health and Life Sciences at Aston University has been appointed as the new executive editor of the journal, BBA Biomembranes.
Professor Roslyn Bill is sharing the role with Professor Burkhard Bechinger of the University of Strasbourg and will be jointly responsible for the editorial direction of the journal, including overseeing the peer review process of submissions.
Roslyn's own area of research focuses on membrane protein structure, function and regulation. She is particularly interested in the regulation of aquaporin water channels in the brain and their development as drug targets to prevent life-threatening brain swelling.
BBA Biomembranes is part of a family of 10 Biochimica et Biophysica Acta (BBA) journals, which are celebrating their 75th year of continuous publication in 2022. They were the first international journals to cover the joint fields of biochemistry and biophysics.
Commenting on her appointment, Roslyn said: “I am delighted and honoured to join BBA Biomembranes as Executive Editor in BBA’s 75th anniversary year.
“The journal has an international reputation for publishing high-quality articles in all aspects of membrane biology and biophysics. I look forward to working with the BBAMEM team to drive the journal’s continuing success.”
Areas of research covered by BBA Biomembranes include: membrane structure, function and biomolecular organization, membrane proteins, receptors, channels and anchors, fluidity and composition, model membranes and liposomes, membrane surface studies and ligand interactions, transport studies and membrane dynamics.
For more information on Professor Bill’s research, visit the research pages.
For more information about studying in the School of Biosciences at Aston University, please visit our website.
Roslyn Bill Professor of Biotechnology
Professor Bill's research on water flow in the body has revealed how to develop drugs that prevent brain swelling after injury or disease.